Found 34 matching trials
CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation PHASE1 The investigators propose a nonrandomized, Phase I study to assess the safe...
Show More Location
Hammersmith Hospital
Learn More & Join Trial
CIML NK Cell in Head & Neck Cancer PHASE1 This research study is evaluating the safety and efficacy of a combination ...
Show More Location
Dana Farber Cancer Institute
Learn More & Join Trial
A Study of Allogenic Natural Killer Cells in Combination With Trastuzumab and Pertuzumab in Adult Patients With Refractory Metastatic Her2 Positive Breast Cancer. NK-ACT-BC_2020 PHASE1 Breast cancer is the second most common invasive malignancy and the leading...
Show More Learn More & Join Trial
Phase I/II Clinical Trial of Universal Donor CD33 CAR Natural Killer Cells for AML PHASE1 This phase 1/2 study is testing a new treatment for acute myeloid leukemia ...
Show More Location
Nationwide Children's Hospital
Learn More & Join Trial
Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer PHASE1 RATIONALE: Giving an infusion of natural killer cells from a donor after a ...
Show More Location
University of Ulsan, Asan Medical Center
Learn More & Join Trial
Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors PHASE1 This phase I trial studies the side effects and best dose of cord blood-der...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Off-the-shelf CD123 CAR-NK for R/R AML EARLY_PHASE1 This is a single-centre, single-arm, open-label, first-in-human (FIH) study...
Show More Location
Peking University People's Hospital
Learn More & Join Trial
Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL) PHASE2 The goal of this clinical research study is to learn if transferring the do...
Show More Location
UT MD Anderson Cancer Center
Learn More & Join Trial
Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies PHASE2 In this study the investigators investigate a cell therapy strategy that co...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial
NK Cells Plus ICI for SCLC Maintenance PHASE2 This research study is designed for patients with extensive-stage small cel...
Show More Location
Tianjin First Central Hospital
Learn More & Join Trial